Cohort study of off-label use of low-dose IL-2 therapy for systemic autoimmune diseases - Sorbonne Université Access content directly
Journal Articles Clinical and experimental rheumatology Year : 2022

Dates and versions

hal-03868254 , version 1 (24-02-2023)

Identifiers

Cite

Omar Al Tabaa, Sabrina Hamroun, Céline Leplay, Olivier Fain, David Klatzmann, et al.. Cohort study of off-label use of low-dose IL-2 therapy for systemic autoimmune diseases. Clinical and experimental rheumatology, 2022, 40 (9), pp.1809-1810. ⟨10.55563/clinexprheumatol/2le8p4⟩. ⟨hal-03868254⟩
15 View
2 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More